Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Bioventix (BVXP) Share Price & Analysis

BVXP Stock Chart & Stats

GBX 2,000.00-GBX 25.00(-1.23%)
At close: 4:30 PM GMT
GBX 1,500GBX 1,750GBX 2,0003 Aug17 Aug1 Sep14 Sep28 Sep12 Oct26 Oct
Day’s Range
GBX 2,000.00 - GBX 2,100.00
52-Week Range
GBX 1,300.00 - GBX 2,255.00
Previous Close
GBX 2,025.00
Volume
13.43K
Average Volume (3M)
17.02K
Market Cap
GBP 104.50M
Enterprise Value
GBP 80.96M
Total Cash (Recent Filing)
GBP 5.26M
Total Debt (Recent Filing)
GBP 10.97K
Price to Earnings (P/E)
13.8
Beta
0.57
Next Earnings
Mar 29, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
Nov 05, 2026
Dividend Yield
7.50%

Bulls Say, Bears Say

Bulls Say

Exceptional Profitability

Exceptionally high and stable margins indicate strong earnings power in Bioventix’s antibody and diagnostic-reagent model. Sustained profitability provides internal funding for operations and shareholder returns, while creating resilience if revenue growth remains modest over the next several quarters.

Minimal Financial Leverage

The nearly debt-free balance sheet materially reduces interest burden, refinancing exposure, and financial distress risk. Strong equity and minimal leverage give Bioventix flexibility to maintain operations, fund priorities, and withstand weaker demand without relying heavily on external capital.

Strong Cash Conversion

Close alignment between earnings, operating cash flow, and free cash flow suggests that reported profits are highly cash-realized rather than dependent on accounting effects. Persistent positive free cash flow strengthens financial flexibility and supports durable distributions or reinvestment.

Bears Say

Recent Revenue Slowdown

The shift from positive revenue growth in 2021–2024 to slight contraction in 2025 and modest growth in 2026 signals weaker top-line momentum. If sustained, slower growth could limit operating leverage, reduce expansion opportunities, and place greater reliance on existing margins.

Uneven Free Cash Flow Growth

Although free cash flow remained positive, uneven year-to-year growth introduces variability into the pace at which Bioventix can accumulate cash or increase distributions. The pattern warrants monitoring because repeated softness could weaken the consistency of internally funded growth.

Limited Balance-sheet Expansion

A balance sheet that is not clearly expanding may indicate that the company’s financial strength is being sustained primarily through profitability rather than broader asset or equity growth. This could constrain the scale of future expansion if revenue momentum remains subdued.

Bioventix News

BVXP FAQ

What was Bioventix’s price range in the past 12 months?
Bioventix lowest share price was 1300.00 p and its highest was 2255.00 p in the past 12 months.
What is Bioventix’s market cap?
Bioventix’s market cap is £104.50M.
When is Bioventix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioventix’s earnings last quarter?
Bioventix released its earnings results on Oct 26, 2026. The company reported 0.75 p earnings per share for the quarter, beating the consensus estimate of 0.66 p by 0.09 p.
Is Bioventix overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bioventix pay dividends?
Bioventix pays a Semiannually dividend of 80 p which represents an annual dividend yield of 7.5%. See more information on Bioventix dividends here
What is Bioventix’s EPS estimate?
Bioventix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioventix have?
Bioventix has 5,224,860 shares outstanding.
What happened to Bioventix’s price movement after its last earnings report?
Bioventix reported an EPS of 0.75 p in its last earnings report, beating expectations of 0.66 p. Following the earnings report the stock price went down -1.25%.
Which hedge fund is a major shareholder of Bioventix?
Currently, no hedge funds are holding shares in GB:BVXP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology